Skip to content

Enovis ENOV Return on equity

Return on equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
26.4%-3.0pp
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
6.1%-1.2pp
ESAB logo
ESABESAB
10.1%-5.2pp
Vericel logo
VericelVCEL
6.6%+5.5pp
Globus Medical logo
Globus MedicalGMED
13.3%+8.7pp
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
2.2%+1.1pp

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Calculated from Enovis’s reported figures.

Based on trailing twelve months.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's return on equity?
Enovis (ENOV) reported return on equity of -55.5% in Q1 2026.
How has Enovis's return on equity changed year-over-year?
Enovis's return on equity decreased by 103.3% year-over-year, from -27.3% to -55.5%.
What is the long-term trend for Enovis's return on equity?
Over 5 years (2020 to 2025), Enovis's return on equity has grown at a 116.8% compound annual growth rate (CAGR), from 1.2% to -58.5%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.